Brief: Hamlet Pharma Gets Patent Granted In Europe
Nov 17 (Reuters) - Hamlet Pharma AB HAMLET.TE :
* NEUTRACEUTICAL PATENT GRANTED IN EUROPE
* PATENT IS VALID UNTIL AUGUST 8, 2033
Source text for Eikon: ID:nWkr8ZS72B
Further company coverage: HAMLET.TE
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))